Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

New Investigational Drug May Help Fight Depression

Research Center: Neuro Trials Victoria (NTVIC)
Location: 1 Beck Court, Noble Park, VIC 3174
Lead Doctor: Peter Farnbach MD
Ethics Committee: Bellberry Limited HREC

Background

Millions of people suffer from depression daily. Many people with depression find that antidepressants alone can’t adequately address all of their symptoms.

This study is evaluating an investigational drug designed to work in tandem with antidepressants to see if it might help improve unresolved symptoms of depression. The medication is a tablet that dissolves under the tongue.

This study seeks men and women between the ages of 18 & 70 who currently suffer from major depressive disorder for more than 8 weeks, but less than 5 years. Participants will be randomised and will receive either the experimental drug or the placebo, there is a 50 percent chance that a participant will receive either the experimental drug or placebo. Participants are required to attend 14 to 20 study visits at the research site over a 5 month period, and could experience an improvement in depression symptoms.

Benefits of Participation

  • You could experience an improvement in your depression symptoms.
  • You will be helping to advance medical research.
  • You will be given the study drug free of charge

Your Rights

  • If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
  • Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
  • Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

  • Men and women aged 18 to 70 who suffer from major depressive disorder.
  • Able to attend 14 to 20 study visits at the research site over approximately 5 months

What Next?

  1. Click the link below to enter your contact details and answer some eligibility questions.
  2. The research centre will then contact you by phone to discuss the trial and answer your questions.
Click Here to Enter Your Contact Details and Be Contacted by Phone About the Trial

Is This Study Not For You?

Enter your details to be notified via email about new studies in your area

Is This Study Not For You?

Enter your details to be notified via email about new studies in your area

Gender(Required)